Exact Mass: 389.1627

Exact Mass Matches: 389.1627

Found 500 metabolites which its exact mass value is equals to given mass value 389.1627, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

Hetacillin

(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C19H23N3O4S (389.1409)


Hetacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name penicillin can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Hetacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Hetacillin results from the inhibition of cell wall synthesis and is mediated through Hetacillin binding to penicillin binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01074

   

Balofloxacin

Balofloxacin, (R)-

C20H24FN3O4 (389.1751)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Diphemanil Methylsulfate

Diphenmanil (methylsulfate)

C21H27NO4S (389.1661)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics Diphemanil methylsulfate is a quaternary ammonium anticholinergic. It binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids as well as saliva and sweat. IC50 value: Target: mAChR Diphemanil Methylsulfate exerts its action by primarily binding the muscarinic M3 receptor. M3 receptors are located in the smooth muscles of the blood vessels, as well as in the lungs. This means they cause vasodilation and bronchoconstriction. They are also in the smooth muscles of the gastrointestinal tract (GIT), which help in increasing intestinal motility and dilating sphincters. The M3 receptors are also located in many glands which help to stimulate secretion in salivary glands and other glands of the body.

   

isoroquefortine C

2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 10b-(1,1-dimethyl-2-propenyl)-6,10b,11,11a-tetrahydro-3-(1H-imidazol-4-ylmethylene)-, (3E,5aS,10bR,11aS)-

C22H23N5O2 (389.1852)


   

Tadalafil

(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),11,13,15-tetraene-4,7-dione

C22H19N3O4 (389.1375)


Tadalafil is an orally adminstered drug used to treat male erectile dysfunction (impotence). It is marketed worldwide under the brand name Cialis. It is a phosphodiesterase 5 (PDE5) inhibitor. Tadalafils distinguishing pharmacologic feature is its longer half-life (17.5 hours) compared with Viagra and Levitra (4-5 hours). This longer half-life results in a longer duration of action and is, in part, responsible for the Cialis nickname of the weekend pill. This longer half-life also is the basis of current investigation for tadalafils use in pulmonary arterial hypertension as a once-daily therapy. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Roquefortine

(4E)-4-(1H-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10(15),11,13-triene-3,6-dione

C22H23N5O2 (389.1852)


Roquefortine is found in milk and milk products. Roquefortine is a metabolite of Penicillium roquefortii, Penicillium commune, Penicillium cyclopium, Penicillium farinosum and many other Penicillium species Common constituent of blue chees. Roquefortine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=58735-64-1 (retrieved 2024-10-11) (CAS RN: 58735-64-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Gemifloxacin

7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C18H20FN5O4 (389.1499)


Gemifloxacin is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV, which are essential for bacterial growth. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine

4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexaazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2,4,7,11-pentaen-7-amine

C20H19N7O2 (389.16)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists SCH442416 is a potent, selective and brain-penetrant antagonist of adenosine A2A receptor (A2AR), with Kis of 0.048 and 0.5 nM for human and rat A2AR respectively. SCH442416 displays more than 23000-fold selectivity over A1R, A2BR, and A3R (Ki=1111, 10000, and 10000 nM, respectively). SCH442416 can be used for imaging of adenosine A2A receptors in rat and primate brain[1][2].

   

Balofloxacin

1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C20H24FN3O4 (389.1751)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether

2-(1-methoxy-1-{3-[(naphthalen-2-yl)methoxy]phenyl}propyl)-1,3-thiazole

C24H23NO2S (389.1449)


   

Cytidine, 2'-deoxy-2',2'-difluoro-N-(1-oxo-2-propylpentyl)-

N-{1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}-2-propylpentanamide

C17H25F2N3O5 (389.1762)


   

Ilginatinib

N2-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine

C21H20FN7 (389.1764)


   

Reproterol

7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C18H23N5O5 (389.1699)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

   

7-[(3R)-3-(Aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid

7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C18H20FN5O4 (389.1499)


   

(+)-Epolactaene

(+)-Epolactaene

C21H27NO6 (389.1838)


   

Stephamiersine

Stephamiersine

C21H27NO6 (389.1838)


   

14-Hydroxyisostephodeline

14-Hydroxyisostephodeline

C21H27NO6 (389.1838)


   

N,O-Dimethyloxostephine

N,O-Dimethyloxostephine

C20H23NO7 (389.1474)


   

Xanthoanthrafil

Xanthoanthrafil

C19H23N3O6 (389.1587)


   

5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate

5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate

C21H24ClNO4 (389.1394)


   
   
   

5-(4-methoxyphenyl)-N-[(5-methyl-2-phenyl-4-triazolyl)methyl]-4-oxazolecarboxamide

5-(4-methoxyphenyl)-N-[(5-methyl-2-phenyl-4-triazolyl)methyl]-4-oxazolecarboxamide

C21H19N5O3 (389.1488)


   

N-(5-Bromopentyl) UR-144

N-(5-Bromopentyl) UR-144

C21H28BrNO (389.1354)


   
   

JWH-122 N-(5-chloropentyl) analog

JWH-122 N-(5-chloropentyl) analog

C25H24ClNO (389.1546)


   

2,3,10-trimethoxy-14-methyl-5-oxo-5,13-dihydro-indolo[2,3:3,4]pyrido[2,1-b]quinazolinium betaine|Euxylophorin-D|Euxylophorine D

2,3,10-trimethoxy-14-methyl-5-oxo-5,13-dihydro-indolo[2,3:3,4]pyrido[2,1-b]quinazolinium betaine|Euxylophorin-D|Euxylophorine D

C22H19N3O4 (389.1375)


   
   

11-O-acetyl-1,2beta-epoxyambelline

11-O-acetyl-1,2beta-epoxyambelline

C20H23NO7 (389.1474)


   
   

MEGxp0_000037

MEGxp0_000037

C20H23NO7 (389.1474)


   

1-O-acetyl-3-O-methylnarcissidine

1-O-acetyl-3-O-methylnarcissidine

C21H27NO6 (389.1838)


   
   

Asperdiazapinone B

Asperdiazapinone B

C23H23N3O3 (389.1739)


   

Asperdiazapinone D

Asperdiazapinone D

C23H23N3O3 (389.1739)


   

3-(benzoyloxy-phenyl-methyl)-1-methyl-4-(1-methyl-1H-imidazol-4-yl)-pyrrolidin-2-one|Cynodin|cynodine

3-(benzoyloxy-phenyl-methyl)-1-methyl-4-(1-methyl-1H-imidazol-4-yl)-pyrrolidin-2-one|Cynodin|cynodine

C23H23N3O3 (389.1739)


   

sessilifoliamine A

sessilifoliamine A

C21H27NO6 (389.1838)


   
   
   

N-[(3R,7R)-(-)-jasmonoyl]-(S)-dopa

N-[(3R,7R)-(-)-jasmonoyl]-(S)-dopa

C21H27NO6 (389.1838)


   
   

(3E,6S)-3-(1H-imidazol-5-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}piperazine-2,5-dione|tryhistatin

(3E,6S)-3-(1H-imidazol-5-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}piperazine-2,5-dione|tryhistatin

C22H23N5O2 (389.1852)


   
   
   
   
   
   

MAM2201 N-(4-hydroxypentyl) Metabolite

MAM2201 N-(4-hydroxypentyl) Metabolite

C25H24FNO2 (389.1791)


   
   
   

asparagylglutamyllysine

asparagylglutamyllysine

C15H27N5O7 (389.191)


   
   
   
   
   
   
   
   

glutamylasparagyllysine

glutamylasparagyllysine

C15H27N5O7 (389.191)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Roquefortine C

isoroquefortine C

C22H23N5O2 (389.1852)


CONFIDENCE isolated standard

   

6,7-O,O-dimethyl-N-deacetylisoipecoside aglycon

6,7-O,O-dimethyl-N-deacetylisoipecoside aglycon

C21H27NO6 (389.1838)


   

NCGC00180375-03!

NCGC00180375-03!

C22H23N5O2 (389.1852)


   

C21H24ClNO4_5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate

NCGC00380768-01_C21H24ClNO4_5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate

C21H24ClNO4 (389.1394)


   
   
   

[5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxo-2H-isoquinolin-7-yl] acetate

[5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxo-2H-isoquinolin-7-yl] acetate

C21H24ClNO4 (389.1394)


   

O4-Pyridyloxobutyl-thymidine

O4-Pyridyloxobutyl-thymidine

C19H23N3O6 (389.1587)


   

3-Pyridyloxobutyl-thymidine

3-Pyridyloxobutyl-thymidine

C19H23N3O6 (389.1587)


   

Cialis

Tadalafil - Dark Web Drugs

C22H19N3O4 (389.1375)


A pyrazinopyridoindole that is 2,3,6,7,12,12a-hexahydropyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione substituted at position 2 by a methyl group and at position 6 by a 1,3-benzodioxol-5-yl group (the 6R,12aR-diastereomer). A phosphodiesterase V inhibitor inhibitor, currently marketed in pill form for treating erectile dysfunction under the name Cialis; and under the name Adcirca for the treatment of pulmonary arterial hypertension. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Ala Ala Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C14H23N5O8 (389.1547)


   

Ala Ala Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Ala Ala Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C15H27N5O7 (389.191)


   

Ala Ala Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C15H27N5O7 (389.191)


   

Ala Asp Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]propanamido]-3-carbamoylpropanoic acid

C14H23N5O8 (389.1547)


   

Ala Asp Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]acetamido}hexanoic acid

C15H27N5O7 (389.191)


   

Ala Asp Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]acetamido}-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Ala Asp Lys Gly

(3S)-3-{[(1S)-5-amino-1-[(carboxymethyl)carbamoyl]pentyl]carbamoyl}-3-[(2S)-2-aminopropanamido]propanoic acid

C15H27N5O7 (389.191)


   

Ala Asp Asn Ala

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Ala Asp Gln Gly

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Ala Glu Gly Asn

(4S)-4-[(2S)-2-aminopropanamido]-4-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Ala Glu Asn Gly

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Ala Gly Asp Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carboxypropanamido]hexanoic acid

C15H27N5O7 (389.191)


   

Ala Gly Asp Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Ala Gly Glu Asn

(4S)-4-{2-[(2S)-2-aminopropanamido]acetamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Ala Gly Gly Trp

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C18H23N5O5 (389.1699)


   

Ala Gly Lys Asp

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]butanedioic acid

C15H27N5O7 (389.191)


   

Ala Gly Asn Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]pentanedioic acid

C14H23N5O8 (389.1547)


   

Ala Gly Gln Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Ala Gly Trp Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C18H23N5O5 (389.1699)


   

Ala Lys Asp Gly

(3S)-3-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H27N5O7 (389.191)


   

Ala Lys Gly Asp

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}butanedioic acid

C15H27N5O7 (389.191)


   

Ala Asn Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Ala Asn Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Ala Asn Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Ala Asn Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}pentanedioic acid

C14H23N5O8 (389.1547)


   

Ala Asn Ser Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Ala Asn Val Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Ala Gln Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]propanamido]-3-hydroxybutanoic acid

C15H27N5O7 (389.191)


   

Ala Gln Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C14H23N5O8 (389.1547)


   

Ala Gln Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}butanedioic acid

C14H23N5O8 (389.1547)


   

Ala Gln Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]propanoic acid

C15H27N5O7 (389.191)


   

Ala Ser Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Ala Ser Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Ala Thr Ala Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]propanamido]-4-carbamoylbutanoic acid

C15H27N5O7 (389.191)


   

Ala Thr Gln Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]propanoic acid

C15H27N5O7 (389.191)


   

Ala Val Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Ala Val Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Ala Trp Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}acetic acid

C18H23N5O5 (389.1699)


   

Cys Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Cys Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O6S (389.1369)


   

Cys Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Cys Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6S (389.1369)


   

Cys Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C14H23N5O6S (389.1369)


   

Cys Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C14H23N5O6S (389.1369)


   

Asp Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]propanamido]-3-carbamoylpropanoic acid

C14H23N5O8 (389.1547)


   

Asp Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]acetamido}hexanoic acid

C15H27N5O7 (389.191)


   

Asp Ala Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]acetamido}-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Asp Ala Lys Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-5-amino-1-[(carboxymethyl)carbamoyl]pentyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C15H27N5O7 (389.191)


   

Asp Ala Asn Ala

(3S)-3-amino-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asp Ala Gln Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asp Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}propanamido]hexanoic acid

C15H27N5O7 (389.191)


   

Asp Gly Ala Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}propanamido]-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Asp Gly Lys Ala

(3S)-3-amino-3-[({[(1S)-5-amino-1-{[(1S)-1-carboxyethyl]carbamoyl}pentyl]carbamoyl}methyl)carbamoyl]propanoic acid

C15H27N5O7 (389.191)


   

Asp Gly Gln Ala

(3S)-3-amino-3-[({[(1S)-3-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}propyl]carbamoyl}methyl)carbamoyl]propanoic acid

C14H23N5O8 (389.1547)


   

Asp Lys Ala Gly

(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}pentyl]carbamoyl}propanoic acid

C15H27N5O7 (389.191)


   

Asp Lys Gly Ala

(3S)-3-amino-3-{[(1S)-5-amino-1-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]pentyl]carbamoyl}propanoic acid

C15H27N5O7 (389.191)


   

Asp Asn Ala Ala

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asp Gln Ala Gly

(3S)-3-amino-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asp Gln Gly Ala

(3S)-3-amino-3-{[(1S)-3-carbamoyl-1-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]propyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Glu Ala Gly Asn

(4S)-4-amino-4-{[(1S)-1-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Glu Ala Asn Gly

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Glu Gly Ala Asn

(4S)-4-amino-4-[({[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Glu Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}acetamido)hexanoic acid

C15H27N5O7 (389.191)


   

Glu Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Glu Gly Lys Gly

(4S)-4-amino-4-[({[(1S)-5-amino-1-[(carboxymethyl)carbamoyl]pentyl]carbamoyl}methyl)carbamoyl]butanoic acid

C15H27N5O7 (389.191)


   

Glu Gly Asn Ala

(4S)-4-amino-4-[({[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Glu Gly Gln Gly

(4S)-4-amino-4-[({[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Glu Lys Gly Gly

(4S)-4-amino-4-{[(1S)-5-amino-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)pentyl]carbamoyl}butanoic acid

C15H27N5O7 (389.191)


   

Glu Asn Ala Gly

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Glu Asn Gly Ala

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Glu Gln Gly Gly

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Ala Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carboxypropanamido]hexanoic acid

C15H27N5O7 (389.191)


   

Gly Ala Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Gly Ala Glu Asn

(4S)-4-[(2S)-2-(2-aminoacetamido)propanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Ala Gly Trp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C18H23N5O5 (389.1699)


   

Gly Ala Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]butanedioic acid

C15H27N5O7 (389.191)


   

Gly Ala Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]pentanedioic acid

C14H23N5O8 (389.1547)


   

Gly Ala Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Gly Ala Trp Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C18H23N5O5 (389.1699)


   

Gly Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Gly Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O6S (389.1369)


   

Gly Asp Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]propanamido]hexanoic acid

C15H27N5O7 (389.191)


   

Gly Asp Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]propanamido]-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Gly Asp Lys Ala

(3S)-3-{[(1S)-5-amino-1-{[(1S)-1-carboxyethyl]carbamoyl}pentyl]carbamoyl}-3-(2-aminoacetamido)propanoic acid

C15H27N5O7 (389.191)


   

Gly Asp Gln Ala

(3S)-3-(2-aminoacetamido)-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Gly Glu Ala Asn

(4S)-4-(2-aminoacetamido)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Glu Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]acetamido}hexanoic acid

C15H27N5O7 (389.191)


   

Gly Glu Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]acetamido}-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Gly Glu Lys Gly

(4S)-4-{[(1S)-5-amino-1-[(carboxymethyl)carbamoyl]pentyl]carbamoyl}-4-(2-aminoacetamido)butanoic acid

C15H27N5O7 (389.191)


   

Gly Glu Asn Ala

(4S)-4-(2-aminoacetamido)-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Glu Gln Gly

(4S)-4-(2-aminoacetamido)-4-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Gly Ala Trp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C18H23N5O5 (389.1699)


   

Gly Gly Glu Lys

(2S)-6-amino-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carboxybutanamido]hexanoic acid

C15H27N5O7 (389.191)


   

Gly Gly Glu Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carboxybutanamido]-4-carbamoylbutanoic acid

C14H23N5O8 (389.1547)


   

Gly Gly Lys Glu

(2S)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]pentanedioic acid

C15H27N5O7 (389.191)


   

Gly Gly Gln Glu

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]pentanedioic acid

C14H23N5O8 (389.1547)


   

Gly Gly Trp Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C18H23N5O5 (389.1699)


   

Gly Ile Asn Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Ile Ser Asn

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Lys Ala Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]butanedioic acid

C15H27N5O7 (389.191)


   

Gly Lys Asp Ala

(3S)-3-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H27N5O7 (389.191)


   

Gly Lys Glu Gly

(4S)-4-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H27N5O7 (389.191)


   

Gly Lys Gly Glu

(2S)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}pentanedioic acid

C15H27N5O7 (389.191)


   

Gly Leu Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Leu Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Ala Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]pentanedioic acid

C14H23N5O8 (389.1547)


   

Gly Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Gly Asn Glu Ala

(4S)-4-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Gly Asn Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   

Gly Asn Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Asn Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C15H27N5O7 (389.191)


   

Gly Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H23N5O6S (389.1369)


   

Gly Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   

Gly Gln Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Gly Gln Asp Ala

(3S)-3-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Gly Gln Glu Gly

(4S)-4-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Gly Gln Gly Glu

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}pentanedioic acid

C14H23N5O8 (389.1547)


   

Gly Gln Ser Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Gln Val Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Ile Asn

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-methylpentanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Leu Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-methylpentanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Asn Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-methylpentanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Asn Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-methylpentanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Gln Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Ser Val Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-methylbutanamido]-4-carbamoylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Thr Asn Val

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Thr Val Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Val Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H27N5O7 (389.191)


   

Gly Val Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Gly Val Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H27N5O7 (389.191)


   

Gly Val Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Gly Trp Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]propanamido]acetic acid

C18H23N5O5 (389.1699)


   

Gly Trp Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}propanoic acid

C18H23N5O5 (389.1699)


   

Ile Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Ile Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H27N5O7 (389.191)


   

Ile Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C15H27N5O7 (389.191)


   

Ile Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C15H27N5O7 (389.191)


   
   
   
   
   

Asn Ala Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Asn Ala Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asn Ala Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Asn Ala Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}pentanedioic acid

C14H23N5O8 (389.1547)


   

Asn Cys Gly Pro

(2S)-1-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Asn Cys Pro Gly

2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6S (389.1369)


   

Asn Asp Ala Ala

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Asn Glu Ala Gly

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Asn Glu Gly Ala

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Asn Gly Ala Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]pentanedioic acid

C14H23N5O8 (389.1547)


   

Asn Gly Cys Pro

(2S)-1-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6S (389.1369)


   

Asn Gly Glu Ala

(4S)-4-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C14H23N5O8 (389.1547)


   

Asn Gly Pro Cys

(2R)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   

Asn Pro Cys Gly

2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]acetic acid

C14H23N5O6S (389.1369)


   

Asn Pro Gly Cys

(2R)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   
   

Pro Cys Gly Asn

(2S)-3-carbamoyl-2-{2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]acetamido}propanoic acid

C14H23N5O6S (389.1369)


   

Pro Cys Asn Gly

2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]acetic acid

C14H23N5O6S (389.1369)


   
   

Pro Gly Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}-3-sulfanylpropanamido]propanoic acid

C14H23N5O6S (389.1369)


   

Pro Gly Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   

Pro Asn Cys Gly

2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]acetic acid

C14H23N5O6S (389.1369)


   

Pro Asn Gly Cys

(2R)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-sulfanylpropanoic acid

C14H23N5O6S (389.1369)


   
   

Gln Ala Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C14H23N5O8 (389.1547)


   

Gln Ala Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}butanedioic acid

C14H23N5O8 (389.1547)


   
   

Gln Asp Ala Gly

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Gln Asp Gly Ala

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-3-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C14H23N5O8 (389.1547)


   

Gln Glu Gly Gly

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-4-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)butanoic acid

C14H23N5O8 (389.1547)


   

Gln Gly Ala Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]butanedioic acid

C14H23N5O8 (389.1547)


   

Gln Gly Asp Ala

(3S)-3-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O8 (389.1547)


   

Gln Gly Glu Gly

(4S)-4-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H23N5O8 (389.1547)


   

Gln Gly Gly Glu

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)pentanedioic acid

C14H23N5O8 (389.1547)


   
   
   
   
   
   
   
   
   

Trp Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]acetamido}acetic acid

C18H23N5O5 (389.1699)


   

Trp Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}propanamido]acetic acid

C18H23N5O5 (389.1699)


   

Trp Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)propanoic acid

C18H23N5O5 (389.1699)


   

Gemifloxacin

7-[(4E)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid

C18H20FN5O4 (389.1499)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors A 1,4-dihydro-1,8-naphthyridine with a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a substituted pyrrolin-1-yl group at the 7-position. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

ZM 336372

3-(dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]-benzamide

C23H23N3O3 (389.1739)


ZM 336372 is a potent inhibitor of the protein kinase c-Raf. The IC50 value is 0.07 μM in the standard assay, which contains 0.1 mM ATP.

   

Roquefortine

(4E)-4-(1H-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0^{2,7}.0^{10,15}]hexadeca-10(15),11,13-triene-3,6-dione

C22H23N5O2 (389.1852)


   

N-jasmonoyl-L-dopa

N-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-L-dihydroxyphenylalanine

C21H27NO6 (389.1838)


   

icas#2

(2S,3R,5R,6R)-5-hydroxy-2-methyl-6-(((R)-5-oxohexan-2-yl)oxy)tetrahydro-2H-pyran-3-yl 1H-indole-3-carboxylate

C21H27NO6 (389.1838)


   
   

boc-3-(1-pyrenyl)-l-alanine

boc-3-(1-pyrenyl)-l-alanine

C24H23NO4 (389.1627)


   

Benzoyl Leucomethylene Blue

Benzoyl Leucomethylene Blue

C23H23N3OS (389.1562)


   

GSK-J1

3-[[2-Pyridin-2-Yl-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)pyrimidin-4-Yl]amino]propanoic Acid

C22H23N5O2 (389.1852)


   
   

12-epi-TadalafilTadalafil

12-epi-TadalafilTadalafil

C22H19N3O4 (389.1375)


   

6-epi-Tadalafil

6-epi-Tadalafil

C22H19N3O4 (389.1375)


   

LY2334737

Cytidine, 2-deoxy-2,2-difluoro-N-(1-oxo-2-propylpentyl)-

C17H25F2N3O5 (389.1762)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor

   

Diphenyl(1-propoxy)essigsaeure-piperid-4-yl-esterhydrochlorid

Diphenyl(1-propoxy)essigsaeure-piperid-4-yl-esterhydrochlorid

C22H28ClNO3 (389.1758)


   
   

Epistephamiersine

Epistephamiersine

C21H27NO6 (389.1838)


   

Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)

Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)

C22H23N5O2 (389.1852)


   
   

3-(3,4-DIETHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

3-(3,4-DIETHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C23H23N3O3 (389.1739)


   

H-Thr(Bzl)-Obzl.oxalate

H-Thr(Bzl)-Obzl.oxalate

C20H23NO7 (389.1474)


   

(6E)-2,4-ditert-butyl-6-[(4-chloro-2-nitrophenyl)hydrazinylidene]cyclohexa-2,4-dien-1-one

(6E)-2,4-ditert-butyl-6-[(4-chloro-2-nitrophenyl)hydrazinylidene]cyclohexa-2,4-dien-1-one

C20H24ClN3O3 (389.1506)


   

8-Desmethoxy-8-fluoro Moxifloxacin

8-Desmethoxy-8-fluoro Moxifloxacin

C20H21F2N3O3 (389.1551)


   
   

3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-(3-Methyl-1-piperazinyl)-4-oxo-

3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-(3-Methyl-1-piperazinyl)-4-oxo-

C20H24FN3O4 (389.1751)


   

4-[2-(4-tert-Butoxycarbonylpiperazin-1-yl)thiazol-4-yl]benzoic acid

4-[2-(4-tert-Butoxycarbonylpiperazin-1-yl)thiazol-4-yl]benzoic acid

C19H23N3O4S (389.1409)


   

benzyl 3-(3-chlorophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate

benzyl 3-(3-chlorophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate

C21H24ClNO4 (389.1394)


   

3-N-BOC-AMINO-3-(4-CHLOROPHENYL)PROPIONIC ACID BENZYL ESTER

3-N-BOC-AMINO-3-(4-CHLOROPHENYL)PROPIONIC ACID BENZYL ESTER

C21H24ClNO4 (389.1394)


   

PHENYL (4-(4-(4-HYDROXYPHENYL)PIPERAZIN-1-YL)PHENYL)CARBAMATE

PHENYL (4-(4-(4-HYDROXYPHENYL)PIPERAZIN-1-YL)PHENYL)CARBAMATE

C23H23N3O3 (389.1739)


   

ISO-PROPYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

ISO-PROPYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

C17H27NO9 (389.1686)


   
   

boc-3-(1-pyrenyl)-d-alanine

boc-3-(1-pyrenyl)-d-alanine

C24H23NO4 (389.1627)


   

N-ethylcarbazole-3-carbaldehyde diphenylhydrazone

N-ethylcarbazole-3-carbaldehyde diphenylhydrazone

C27H23N3 (389.1892)


   

Solcitinib

Solcitinib

C22H23N5O2 (389.1852)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant

   

Nicardipine Methyl Amino Derivative

Nicardipine Methyl Amino Derivative

C19H23N3O6 (389.1587)


   

N-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-N,N,N-trimethyl-1,3-propanediamine

N-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-N,N,N-trimethyl-1,3-propanediamine

C21H28ClN3S (389.1692)


   

Azilsartan Impurity

Azilsartan Impurity

C23H23N3O3 (389.1739)


   

2-SEC-BUTYL-4,6-DINITROPHENOL TRIETHANOLAMINE SALT

2-SEC-BUTYL-4,6-DINITROPHENOL TRIETHANOLAMINE SALT

C16H27N3O8 (389.1798)


   

Ethyl 3-amino-2-{[(2-carbamoyl-4-biphenylyl)methyl]amino}benzoat e

Ethyl 3-amino-2-{[(2-carbamoyl-4-biphenylyl)methyl]amino}benzoat e

C23H23N3O3 (389.1739)


   

N-[[3-[4-[4-(2-Cyanoethyl)-1-piperazinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide

N-[[3-[4-[4-(2-Cyanoethyl)-1-piperazinyl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide

C19H24FN5O3 (389.1863)


   

Venglustat

Venglustat

C20H24FN3O2S (389.1573)


D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].

   

Brepocitinib

Brepocitinib

C18H21F2N7O (389.1776)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C308 - Immunotherapeutic Agent

   

Ilginatinib

Ilginatinib

C21H20FN7 (389.1764)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor

   

1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E)-

1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 14-(ethylamino)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-3,4-dimethyl-, (3S,4R,5Z,8S,9S,11E)-

C21H27NO6 (389.1838)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether

1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether

C24H23NO2S (389.1449)


   
   

3-[[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid

3-[[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid

C22H23N5O2 (389.1852)


   

H-Glu-Glu-Leu-OH

H-Glu-Glu-Leu-OH

C16H27N3O8 (389.1798)


   

Balofloxacin, (R)-

Balofloxacin, (R)-

C20H24FN3O4 (389.1751)


   

6-{4-[4-(4-Chlorophenyl)piperidin-4-Yl]phenyl}-9h-Purine

6-{4-[4-(4-Chlorophenyl)piperidin-4-Yl]phenyl}-9h-Purine

C22H20ClN5 (389.1407)


   

N-Benzyl-3-(alpha-D-galactos-1-YL)-benzamide

N-Benzyl-3-(alpha-D-galactos-1-YL)-benzamide

C20H23NO7 (389.1474)


   

(2S)-2-(3-carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid

(2S)-2-(3-carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid

C19H24N3O4P (389.1504)


   

Hetacillin

Hetacillin

C19H23N3O4S (389.1409)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01074

   

Reproterol

Reproterol

C18H23N5O5 (389.1699)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

   

N-(4-methoxy-1-methylindazol-3-yl)-1-phenyl-5-propylpyrazole-4-carboxamide

N-(4-methoxy-1-methylindazol-3-yl)-1-phenyl-5-propylpyrazole-4-carboxamide

C22H23N5O2 (389.1852)


   

Acetic acid [1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-hydroxy-3-methylbutan-2-yl] ester

Acetic acid [1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-hydroxy-3-methylbutan-2-yl] ester

C20H23NO7 (389.1474)


   

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate

C15H25N4O8- (389.1672)


   

(2E,4E)-5-[(1R,7S,8R,9R)-7-hydroxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

(2E,4E)-5-[(1R,7S,8R,9R)-7-hydroxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

C21H25O7- (389.16)


   

methyl (2R,3R,4S)-4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethenyl-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylate

methyl (2R,3R,4S)-4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethenyl-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylate

C21H27NO6 (389.1838)


   

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-)

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-)

C15H25N4O8- (389.1672)


   

[(3aR,4S,9bR)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aR,4S,9bR)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H24FN3O (389.1903)


   

Glu-Glu-Ile

Glu-Glu-Ile

C16H27N3O8 (389.1798)


A tripeptide composed of two L-glutamic acid units and L-isoleucine joined in sequence by peptide linkages.

   

2-[[2-[(1-Cyclohexyl-5-tetrazolyl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

2-[[2-[(1-Cyclohexyl-5-tetrazolyl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

C18H23N5O3S (389.1522)


   

4-[3-(2,5-Dimethyl-1-pyrrolyl)-4-(1-pyrrolidinyl)phenyl]sulfonylmorpholine

4-[3-(2,5-Dimethyl-1-pyrrolyl)-4-(1-pyrrolidinyl)phenyl]sulfonylmorpholine

C20H27N3O3S (389.1773)


   

2-(4-((2-Hydroxy-benzoyl)-hydrazonomethyl)-phenoxy)-N-phenyl-acetamide

2-(4-((2-Hydroxy-benzoyl)-hydrazonomethyl)-phenoxy)-N-phenyl-acetamide

C22H19N3O4 (389.1375)


   

(3aS)-2-m-anisyl-10,10-dimethyl-4,9-dihydro-3aH-imidazo[1,5-b]-carboline-1,3-quinone

(3aS)-2-m-anisyl-10,10-dimethyl-4,9-dihydro-3aH-imidazo[1,5-b]-carboline-1,3-quinone

C23H23N3O3 (389.1739)


   

7-Anilino-1-(4-methylphenyl)-5-oxo-[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid ethyl ester

7-Anilino-1-(4-methylphenyl)-5-oxo-[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid ethyl ester

C21H19N5O3 (389.1488)


   

maritinamine Trifluoroacetic acid

maritinamine Trifluoroacetic acid

C18H22F3NO5 (389.145)


A natural product found in Crinum asiaticum var. sinicum.

   

4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide

4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide

C19H23N3O4S (389.1409)


   

2-(3,5-dimethylphenoxy)-N-[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

2-(3,5-dimethylphenoxy)-N-[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

C22H19N3O4 (389.1375)


   

1-(3,4-Dimethoxyphenyl)-3-[[2-(4-ethoxyphenyl)-1-oxoethyl]amino]thiourea

1-(3,4-Dimethoxyphenyl)-3-[[2-(4-ethoxyphenyl)-1-oxoethyl]amino]thiourea

C19H23N3O4S (389.1409)


   

3-[1-[Oxo-(1-phenylcyclopropyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one

3-[1-[Oxo-(1-phenylcyclopropyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one

C23H23N3O3 (389.1739)


   

3-(4-fluorophenyl)-N-[3-(1-imidazolyl)propyl]-1-phenyl-4-pyrazolecarboxamide

3-(4-fluorophenyl)-N-[3-(1-imidazolyl)propyl]-1-phenyl-4-pyrazolecarboxamide

C22H20FN5O (389.1652)


   

3-methyl-4-oxo-1-phthalazinecarboxylic acid [2-(7-ethyl-1H-indol-3-yl)-2-oxoethyl] ester

3-methyl-4-oxo-1-phthalazinecarboxylic acid [2-(7-ethyl-1H-indol-3-yl)-2-oxoethyl] ester

C22H19N3O4 (389.1375)


   

ethyl 4-[2-(2,6-dimethoxybenzoyl)oxyacetyl]-2,5-dimethyl-1H-pyrrole-3-carboxylate

ethyl 4-[2-(2,6-dimethoxybenzoyl)oxyacetyl]-2,5-dimethyl-1H-pyrrole-3-carboxylate

C20H23NO7 (389.1474)


   

3-[2-(2,4-Dimethyl-3-furanyl)-2-oxoethyl]-3-hydroxy-1-(2-phenylethyl)-2-indolone

3-[2-(2,4-Dimethyl-3-furanyl)-2-oxoethyl]-3-hydroxy-1-(2-phenylethyl)-2-indolone

C24H23NO4 (389.1627)


   

N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-phenoxybutanamide

N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-phenoxybutanamide

C22H19N3O4 (389.1375)


   

5-[[1-(2-Methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]methyl]-2-methylthiazole

5-[[1-(2-Methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]methyl]-2-methylthiazole

C23H23N3OS (389.1562)


   

(11aS)-2-(4-methoxybenzyl)-5,5-dimethyl-5,6,11,11a-tetrahydro-1H-imidazo[1,5:1,6]pyrido[3,4-b]indole-1,3(2H)-dione

(11aS)-2-(4-methoxybenzyl)-5,5-dimethyl-5,6,11,11a-tetrahydro-1H-imidazo[1,5:1,6]pyrido[3,4-b]indole-1,3(2H)-dione

C23H23N3O3 (389.1739)


   
   

(15R)-13-[(3-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(3-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C23H23N3O3 (389.1739)


   

(15R)-13-[(4-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(4-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C23H23N3O3 (389.1739)


   

(15S)-13-[(2-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(2-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C23H23N3O3 (389.1739)


   

(15R)-13-[(2-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(2-Methoxyphenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C23H23N3O3 (389.1739)


   

[(3aS,4S,9bS)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aS,4S,9bS)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H24FN3O (389.1903)


   

[(3aR,4R,9bR)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aR,4R,9bR)-8-(3-fluorophenyl)-1-(pyridin-4-ylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H24FN3O (389.1903)


   
   
   
   
   
   
   
   
   
   

(5Z)-5-{(2E)-3-[4-(dimethylamino)phenyl]prop-2-en-1-ylidene}-1-(3,5-dimethylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione

(5Z)-5-{(2E)-3-[4-(dimethylamino)phenyl]prop-2-en-1-ylidene}-1-(3,5-dimethylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione

C23H23N3O3 (389.1739)


   

(6S,7R,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6R,7R,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6R,7S,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

4-[4-[(6S,7S,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6S,7S,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6S,7R,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6S,7R,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6R,7S,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7S,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6S,7R,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6S,7R,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

(1R,5S)-N-(3-fluorophenyl)-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1R,5S)-N-(3-fluorophenyl)-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H20FN5O (389.1652)


   

(6R,7S,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6S,7S,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6S,7R,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6R,7R,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

(6S,7S,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-8-(hydroxymethyl)-4-(1-oxopropyl)-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C23H23N3O3 (389.1739)


   

4-[4-[(6R,7R,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7R,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6R,7S,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7S,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6R,7R,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7R,8R)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   

4-[4-[(6S,7S,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6S,7S,8S)-8-(hydroxymethyl)-2-oxo-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C23H23N3O3 (389.1739)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Sclerotioramine, >=95\\% (LC/MS-UV)

Sclerotioramine, >=95\\% (LC/MS-UV)

C21H24ClNO4 (389.1394)


   

SCH 442416

2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine

C20H19N7O2 (389.16)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists SCH442416 is a potent, selective and brain-penetrant antagonist of adenosine A2A receptor (A2AR), with Kis of 0.048 and 0.5 nM for human and rat A2AR respectively. SCH442416 displays more than 23000-fold selectivity over A1R, A2BR, and A3R (Ki=1111, 10000, and 10000 nM, respectively). SCH442416 can be used for imaging of adenosine A2A receptors in rat and primate brain[1][2].

   
   

ST 18:5;O5;Gly

ST 18:5;O5;Gly

C20H23NO7 (389.1474)


   

ST 19:4;O4;Gly

ST 19:4;O4;Gly

C21H27NO6 (389.1838)


   

AKT-IN-6

AKT-IN-6

C22H20FN5O (389.1652)


AKT-IN-6 (Example 13) is a potent Akt inhibitor. AKT-IN-6 inhibits Akt1, Akt2 and Akt3 with IC50s < 500nM, respectively. (patent WO2013056015A1).

   

Epsilon-(gamma-glutamyl)-lysine (TFA)

Epsilon-(gamma-glutamyl)-lysine (TFA)

C13H22F3N3O7 (389.141)


Epsilon-(gamma-glutamyl)-lysine (H-Glu(H-Lys-OH)-OH) TFA is an N(6)-acyl-L-lysine derivative. The enzyme tissue transglutaminase (tTg) helps the formation of epsilon-(gamma-glutamyl)lysine bonds between ECM components in some disease, such as non-diabetic kidney, glaucoma filtration[1].

   

SIRT-IN-1

SIRT-IN-1

C19H27N5O2S (389.1885)


SIRT-IN-1 is a potent inhibitor of SIRT1/2/3, with IC50s of 15, 10, 33 μM, respectively.

   

(1r,9r,10s)-10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

(1r,9r,10s)-10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

C21H27NO6 (389.1838)


   

(1r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(1s,2s,4r,7s,11r,14r,16s)-16-(dimethylamino)-14-(prop-1-en-2-yl)-8-(propan-2-ylidene)-3,6,15-trioxatetracyclo[9.3.1.1⁴,⁷.0²,⁴]hexadecane-5,9,12-trione

(1s,2s,4r,7s,11r,14r,16s)-16-(dimethylamino)-14-(prop-1-en-2-yl)-8-(propan-2-ylidene)-3,6,15-trioxatetracyclo[9.3.1.1⁴,⁷.0²,⁴]hexadecane-5,9,12-trione

C21H27NO6 (389.1838)


   

methyl (2e,3e,5e,9e)-11-{2,4-dihydroxy-4-methyl-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl}-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,9-trienoate

methyl (2e,3e,5e,9e)-11-{2,4-dihydroxy-4-methyl-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl}-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,9-trienoate

C21H27NO6 (389.1838)


   

[1-methyl-4-(1-methylimidazol-4-yl)-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

[1-methyl-4-(1-methylimidazol-4-yl)-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

C23H23N3O3 (389.1739)


   

(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-yl acetate

(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-yl acetate

C20H23NO7 (389.1474)


   

(2s,7r)-10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

(2s,7r)-10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

C20H23NO7 (389.1474)


   

(1s,8s,10s,11r,12s)-3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

(1s,8s,10s,11r,12s)-3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

C21H27NO6 (389.1838)


   

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6-hydroxy-7-methyl-8-oxoisoquinolin-7-yl acetate

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6-hydroxy-7-methyl-8-oxoisoquinolin-7-yl acetate

C21H24ClNO4 (389.1394)


   

1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate

1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate

C20H23NO7 (389.1474)


   

(1s,8s,10s,11r,12r)-3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

(1s,8s,10s,11r,12r)-3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

C21H27NO6 (389.1838)


   

(1s,4z,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4z,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

(1s,4z,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4z,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

(2s,3r,4r,5r,6s)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-3,5-dimethoxy-6-methyloxan-4-ol

(2s,3r,4r,5r,6s)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-3,5-dimethoxy-6-methyloxan-4-ol

C19H23N3O6 (389.1587)


   

(1r,2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-hydroxy-3-methylbutyl acetate

(1r,2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-hydroxy-3-methylbutyl acetate

C20H23NO7 (389.1474)


   

(1s,4z,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1s,4z,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(1s,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1s,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(1s,4e,6r,7r)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1s,4e,6r,7r)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(2s)-4-[(2s,4s)-1,8-dihydroxy-2,4-dimethyloct-6-en-1-ylidene]-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(2s)-4-[(2s,4s)-1,8-dihydroxy-2,4-dimethyloct-6-en-1-ylidene]-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H27NO6 (389.1838)


   

(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate

(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate

C20H23NO7 (389.1474)


   

10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

C21H27NO6 (389.1838)


   

(1s,4z,6s,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1s,4z,6s,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

7,17,18-trimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,15,17,19-nonaen-14-one

7,17,18-trimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,15,17,19-nonaen-14-one

C22H19N3O4 (389.1375)


   

1,2,2-tris(1h-indol-3-yl)ethanone

1,2,2-tris(1h-indol-3-yl)ethanone

C26H19N3O (389.1528)


   

4,11'-dimethyl-3'-(4-methyl-5-oxooxolan-2-yl)-13'-oxa-2'-azaspiro[oxolane-2,7'-tricyclo[8.3.0.0²,⁶]tridecan]-10'-ene-5,12'-dione

4,11'-dimethyl-3'-(4-methyl-5-oxooxolan-2-yl)-13'-oxa-2'-azaspiro[oxolane-2,7'-tricyclo[8.3.0.0²,⁶]tridecan]-10'-ene-5,12'-dione

C21H27NO6 (389.1838)


   

5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate

5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate

C21H24ClNO4 (389.1394)


   

(4z)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(4z)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

C21H27NO6 (389.1838)


   

(2s,10r,12s)-6,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one

(2s,10r,12s)-6,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one

C23H23N3O3 (389.1739)


   

4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid

n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid

C23H23N3O3 (389.1739)


   

(1's,2s,3's,4r,6's)-4,11'-dimethyl-3'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-13'-oxa-2'-azaspiro[oxolane-2,7'-tricyclo[8.3.0.0²,⁶]tridecan]-10'-ene-5,12'-dione

(1's,2s,3's,4r,6's)-4,11'-dimethyl-3'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-13'-oxa-2'-azaspiro[oxolane-2,7'-tricyclo[8.3.0.0²,⁶]tridecan]-10'-ene-5,12'-dione

C21H27NO6 (389.1838)


   

12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

C20H23NO7 (389.1474)


   

(1r,4z,7r,9s)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4z,7r,9s)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

4-(1,8-dihydroxy-2,4-dimethyloct-6-en-1-ylidene)-5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

4-(1,8-dihydroxy-2,4-dimethyloct-6-en-1-ylidene)-5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H27NO6 (389.1838)


   

6,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one

6,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one

C23H23N3O3 (389.1739)


   

(2s,7r)-12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

(2s,7r)-12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

C20H23NO7 (389.1474)


   

(1r,11s,13s,14r,15s,16s)-16-hydroxy-14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-19-one

(1r,11s,13s,14r,15s,16s)-16-hydroxy-14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-19-one

C20H23NO7 (389.1474)


   

(2r)-2-hydroxy-n-[(1s)-1-[(3r)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid

(2r)-2-hydroxy-n-[(1s)-1-[(3r)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid

C20H23NO7 (389.1474)


   

5-hydroxy-3-(1h-imidazol-4-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-1,6-dihydropyrazin-2-one

5-hydroxy-3-(1h-imidazol-4-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-1,6-dihydropyrazin-2-one

C22H23N5O2 (389.1852)


   

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate

C21H24ClNO4 (389.1394)


   

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-3,5-dimethoxy-6-methyloxan-4-ol

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-3,5-dimethoxy-6-methyloxan-4-ol

C19H23N3O6 (389.1587)


   

(1s,4e,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4e,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H23N5O2 (389.1852)


   

(3s)-3-{[6-hydroxy-1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3h-1,4-benzodiazepine-2,5-diol

(3s)-3-{[6-hydroxy-1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3h-1,4-benzodiazepine-2,5-diol

C23H23N3O3 (389.1739)


   

10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one

C20H23NO7 (389.1474)


   

(1s,5s,6s,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1s,5s,6s,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(2s)-3-(3,4-dihydroxyphenyl)-2-({1-hydroxy-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)propanoic acid

(2s)-3-(3,4-dihydroxyphenyl)-2-({1-hydroxy-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)propanoic acid

C21H27NO6 (389.1838)


   

(2s)-2-hydroxy-n-[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid

(2s)-2-hydroxy-n-[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid

C20H23NO7 (389.1474)


   

3-{[6-hydroxy-1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3h-1,4-benzodiazepine-2,5-diol

3-{[6-hydroxy-1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3h-1,4-benzodiazepine-2,5-diol

C23H23N3O3 (389.1739)


   

(s)-[(3s,4r)-1-methyl-4-(1-methylimidazol-4-yl)-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

(s)-[(3s,4r)-1-methyl-4-(1-methylimidazol-4-yl)-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

C23H23N3O3 (389.1739)


   

(1r,5s,6r,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1r,5s,6r,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

(3e,6s)-3-(3h-imidazol-4-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-6h-pyrazine-2,5-diol

(3e,6s)-3-(3h-imidazol-4-ylmethylidene)-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-6h-pyrazine-2,5-diol

C22H23N5O2 (389.1852)


   

3-(3,4-dihydroxyphenyl)-2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)propanoic acid

3-(3,4-dihydroxyphenyl)-2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)propanoic acid

C21H27NO6 (389.1838)


   

(1r,4z,6s,7r)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

(1r,4z,6s,7r)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate

C20H23NO7 (389.1474)


   

1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-hydroxy-3-methylbutyl acetate

1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-hydroxy-3-methylbutyl acetate

C20H23NO7 (389.1474)


   

2-hydroxy-n-[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-2-(5-oxo-2h-furan-2-yl)ethanimidic acid

2-hydroxy-n-[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-2-(5-oxo-2h-furan-2-yl)ethanimidic acid

C20H23NO7 (389.1474)


   

(1s,9s,10s)-10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

(1s,9s,10s)-10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one

C21H27NO6 (389.1838)


   

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-yl acetate

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-yl acetate

C20H23NO7 (389.1474)